NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free NRBO Stock Alerts $3.02 -0.10 (-3.21%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media NeuroBo Pharmaceuticals Stock Price Performance5 Day Performance-10.39%1 Month Performance-32.29%3 Month Performance-1.63%6 Month Performance-12.21%Year-To-Date Performance-18.30%1 Year Performance-45.19% Receive NRBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchHow to camouflage a factory of 53,000 workers"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. NRBO Stock Chart for Wednesday, April, 24, 2024 NRBO Chart by TradingView NeuroBo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$3.12$3.02-3.21%$3.19$2.9942,194 shs$14.83 million04/22/2024$3.37$3.12-7.42%$3.27$3.0823,389 shs$15.32 million04/19/2024$3.40$3.37-0.88%$3.49$3.2620,537 shs$16.55 million04/18/2024$3.46$3.40-1.73%$3.63$3.3522,788 shs$16.69 million04/17/2024$3.40$3.46+1.76%$3.69$3.4611,485 shs$16.99 million04/16/2024$3.53$3.40-3.68%$3.62$3.3312,910 shs$16.69 million Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$3.61$3.53-2.22%$3.73$3.4922,867 shs$17.33 million04/12/2024$3.58$3.61+0.84%$3.95$3.5875,302 shs$17.73 million04/11/2024$3.56$3.58+0.56%$3.69$3.5614,698 shs$17.56 million04/10/2024$3.53$3.56+0.85%$3.66$3.5013,047 shs$17.48 million04/09/2024$3.97$3.53-11.08%$3.93$3.4747,503 shs$17.33 million04/08/2024$3.88$3.97+2.32%$3.97$3.7713,359 shs$19.49 million04/05/2024$3.89$3.88-0.26%$3.94$3.7524,656 shs$19.05 million04/04/2024$3.89$3.89$4.04$3.8224,739 shs$19.10 million04/03/2024$3.93$3.89-1.02%$4.07$3.8013,935 shs$19.10 million04/02/2024$4.06$3.93-3.20%$4.12$3.8527,715 shs$19.06 million04/01/2024$4.09$4.06-0.73%$4.16$3.8049,882 shs$19.70 million03/29/2024$4.09$4.09$4.39$4.0735,570 shs$19.84 million03/28/2024$4.34$4.09-5.76%$4.39$4.0734,044 shs$19.84 million03/27/2024$4.30$4.34+0.93%$4.57$4.1721,612 shs$21.05 million03/26/2024$4.39$4.30-1.94%$4.38$4.2273,948 shs$20.86 million03/25/2024$4.46$4.39-1.68%$4.60$4.3450,797 shs$21.27 million03/22/2024$4.58$4.46-2.62%$4.73$4.4022,616 shs$21.63 million03/21/2024$4.39$4.58+4.33%$4.67$4.3967,872 shs$22.21 million03/20/2024$4.11$4.39+6.81%$4.44$4.1440,291 shs$21.29 million03/19/2024$4.34$4.11-5.30%$4.40$4.1168,991 shs$19.93 million03/18/2024$4.60$4.34-5.65%$4.65$4.3236,590 shs$21.05 million03/15/2024$4.55$4.60+1.10%$4.72$4.5431,075 shs$22.31 million03/14/2024$4.47$4.55+1.79%$4.71$4.3848,003 shs$22.07 million03/13/2024$4.87$4.47-8.21%$5.05$4.34314,434 shs$21.68 million03/12/2024$5.12$4.87-4.88%$5.28$4.7652,195 shs$23.63 million03/11/2024$5.36$5.12-4.48%$5.53$5.1143,095 shs$24.83 million03/08/2024$5.46$5.36-1.83%$5.65$5.3630,464 shs$26.00 million03/07/2024$5.61$5.46-2.67%$5.71$5.35113,303 shs$27.22 million03/06/2024$6.29$5.61-10.81%$6.29$5.55140,365 shs$27.21 million03/05/2024$6.52$6.29-3.53%$6.68$6.1483,520 shs$30.51 million03/04/2024$6.24$6.52+4.49%$6.75$6.06261,398 shs$31.62 million03/01/2024$5.79$6.24+7.77%$6.34$5.52407,225 shs$30.26 million02/29/2024$5.12$5.79+13.09%$5.97$5.153.33 million shs$28.08 million02/28/2024$4.81$5.12+6.44%$5.30$4.8560,237 shs$24.83 millionGlobal crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know.02/27/2024$5.59$4.81-13.95%$5.66$4.76103,778 shs$23.34 million02/26/2024$5.30$5.59+5.47%$5.61$5.3582,136 shs$27.11 million02/23/2024$5.73$5.30-7.57%$5.85$5.2063,371 shs$25.71 million02/22/2024$5.82$5.73-1.48%$5.86$5.5083,758 shs$27.82 million02/21/2024$5.35$5.82+8.79%$5.84$5.27123,318 shs$28.23 million02/20/2024$5.27$5.35+1.52%$5.39$4.9260,378 shs$25.95 million02/19/2024$5.27$5.27$5.30$4.74118,900 shs$25.56 million02/16/2024$4.83$5.27+9.11%$5.30$4.74118,662 shs$25.56 million02/15/2024$4.77$4.83+1.26%$4.96$4.6927,776 shs$23.43 million02/14/2024$4.93$4.77-3.25%$4.94$4.6358,658 shs$23.13 million02/13/2024$5.00$4.93-1.40%$5.05$4.7635,740 shs$23.91 million02/12/2024$4.56$5.00+9.65%$5.10$4.44169,324 shs$24.26 million02/09/2024$4.33$4.56+5.31%$4.58$4.3065,510 shs$22.12 million02/08/2024$4.62$4.33-6.28%$4.68$4.3390,137 shs$21 million02/07/2024$4.43$4.62+4.29%$4.89$4.24220,224 shs$22.41 million02/06/2024$5.00$4.43-11.40%$5.00$4.18358,604 shs$21.49 million02/05/2024$5.13$5.00-2.53%$5.24$4.68455,862 shs$24.25 million02/02/2024$5.47$5.13-6.22%$6.42$4.566.92 million shs$24.88 million02/01/2024$3.27$5.47+67.28%$6.06$3.9668.44 million shs$26.53 million01/31/2024$3.36$3.27-2.68%$3.39$3.1931,289 shs$15.86 million01/30/2024$3.35$3.36+0.30%$3.38$3.2513,432 shs$16.30 million01/29/2024$3.07$3.35+9.12%$3.35$3.0042,990 shs$16.25 million01/26/2024$3.02$3.07+1.66%$3.11$3.026,863 shs$14.89 million01/25/2024$3.07$3.02-1.63%$3.12$3.025,502 shs$14.65 million01/24/2024$3.18$3.07-3.46%$3.28$3.0312,947 shs$14.89 million01/23/2024$3.31$3.18-3.93%$3.39$2.9064,428 shs$15.42 million Related Companies: Avalo Therapeutics Stock Price Chart Aytu BioPharma Stock Price Chart Pieris Pharmaceuticals Stock Price Chart Talphera Stock Price Chart Orgenesis Stock Price Chart Minerva Neurosciences Stock Price Chart Galecto Stock Price Chart Cocrystal Pharma Stock Price Chart VBI Vaccines Stock Price Chart Traws Pharma Stock Price Chart Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRBO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.